CINJ physicians named among 2012 list of U.S. News Top Doctors

CINJ physicians named among 2012 list of U.S. News Top Doctors

News and Articles
Oct 5 2012

Several physicians at The Cancer Institute of New Jersey (CINJ), who are faculty members at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, have been named as a ‘Top Doctor’ by U.S. News & World Report. CINJ is the state’s only Comprehensive Cancer Center as designated by the National Cancer Institute and a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Each year, U.S. News & World Report releases a list of the nation’s top physicians in conjunction with Castle Connolly Medical Ltd., which publishes America’s Top Doctors. Based on peer nominations, attributes such as clinical skills, training, achievements and other criteria are reviewed and assessed by a physician-led research team. The listing represents nearly 31,000 of the nation’s 800,000 physicians.

CINJ physicians on this year’s list are:

Joseph Aisner, MD, Associate Director, Clinical Science; specialty: lung cancer

David A. August, MD, Chief, Surgical Oncology; specialty: gastrointestinal malignancies

Robert S. DiPaola, MD, Director, CINJ; specialty: prostate cancer

James S. Goydos, MD, Director, Melanoma and Soft Tissue Oncology Program; specialty: melanoma and skin cancer

Bruce G. Haffty, MD, Chair, Radiation Oncology; specialty: breast cancer

Thomas Kearney, MD, FACS, Director, Breast Care Services; specialty: breast cancer

Lorna Rodriguez, MD, PhD, Director, Precision Medicine; specialty: gynecologic cancers

Roger Strair, MD, PhD, Chief, Hematologic Malignancies/Hematopoietic Stem Cell Transplantation; specialty: leukemia and lymphoma

Deborah L. Toppmeyer, MD, Chief Medical Officer; specialty: breast cancer

Robert E. Weiss, MD, urologic oncologist; specialty: urologic cancers

“Serving as New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, CINJ carries a tremendous responsibility in providing the latest novel treatments to patients through cutting-edge research. We are honored that our peers across the nation recognize dedicated CINJ physicians who by collaborating with a larger team of nationally known researchers and clinicians work toward eradicating cancer,” said CINJ Director Robert S. DiPaola, MD, who is also the associate dean for oncology programs at UMDNJ-Robert Wood Johnson Medical School.


The Cancer Institute of New Jersey


Rate article
Add a comment